Veröffentlichungen | Max Delbrück Center

228 Ergebnisse:

Active Filter:

16. März 2023 / Mol Cell

Evolutionary origins and interactomes of human, young microproteins and small peptides translated from short open reading frames

C.L. Sandmann
J.F. Schulz
J. Ruiz-Orera
M. Kirchner
M. Ziehm
E. Adami
M. Marczenke
A. Christ
N. Liebe
J. Greiner
A. Schoenenberger
M.B. Mücke
N. Liang
R.L. Moritz
Z. Sun
E.W. Deutsch
M. Gotthardt
J.M. Mudge
J.R. Prensner
T.E. Willnow
P. Mertins
S. van Heesch
N. Hubner

14. März 2023 / J Immunother Cancer

Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

L. Immisch
G. Papafotiou
O. Popp
P. Mertins
T. Blankenstein
G. Willimsky

01. März 2023 / Nat Immunol

IFNγ binding to extracellular matrix prevents fatal systemic toxicity

J. Kemna
E. Gout
L. Daniau
J. Lao
K. Weißert
S. Ammann
R. Kühn
M. Richter
C. Molenda
A. Sporbert
D. Zocholl
R. Klopfleisch
H. Lortat-Jacob
P. Aichele
T. Kammertoens
T. Blankenstein

16. Februar 2023 / Front Immunol

Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors

L. Immisch
G. Papafotiou
N. Gallarín Delgado
V. Scheuplein
A. Paschen
T. Blankenstein
G. Willimsky

01. Februar 2023 / Int J Mol Sci

Disintegration of the NuRD complex in primary human muscle stem cells in critical illness myopathy

J. Schneider
D. Sundaravinayagam
A. Blume
A. Marg
S. Grunwald
E. Metzler
H. Escobar
S. Müthel
H. Wang
T. Wollersheim
S. Weber-Carstens
A. Akalin
M. Di Virgilio
B. Tursun
S. Spuler

01. Februar 2023 / J Immunother Cancer

Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy

N. Plewa
L. Poncette
T. Blankenstein

25. Januar 2023 / Nucleic Acids Res

CYCLeR - a novel tool for the full isoform assembly and quantification of circRNAs

S.R. Stefanov
I.M. Meyer

20. Dezember 2022 / Sci Total Environ

SARS-CoV-2 infection dynamics revealed by wastewater sequencing analysis and deconvolution

V.F. Schumann
R.R. de Castro Cuadrat
E. Wyler
R. Wurmus
A. Deter
C. Quedenau
J. Dohmen
M. Faxel
T. Borodina
A. Blume
J. Freimuth
M. Meixner
J.H. Grau
K. Liere
T. Hackenbeck
F. Zietzschmann
R. Gnirss
U. Böckelmann
B. Uyar
V. Franke
N. Barke
J. Altmüller
N. Rajewsky
M. Landthaler
A. Akalin

01. November 2022 / Cancer Immunol Res

Immune phenotypes and target antigens of clonally expanded bone marrow T cells in treatment-naïve multiple myeloma

C. Welters
M.F. Lammoglia Cobo
C.A. Stein
M.T. Hsu
A. Ben Hamza
L. Penter
X. Chen
C. Buccitelli
O. Popp
P. Mertins
K. Dietze
L. Bullinger
A. Moosmann
E. Blanc
D. Beule
A. Gerbitz
J. Strobel
H. Hackstein
H.P. Rahn
K. Dornmair
T. Blankenstein
L. Hansmann

27. Oktober 2022 / J Immunother Cancer

H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma

L. Immisch
G. Papafotiou
O. Popp
P. Mertins
T. Blankenstein
G. Willimsky